Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MicroGen Biotech
Carlow, Leinster, Irelandmicrogenbiotech.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
MicroGen Biotech has developed a patented microbiome technology that uses selected microbial consortia to reduce heavy metal uptake by crops, improve soil health, increase crop yields, and degrade organic pollutants. Their products have demonstrated the ability to lower toxic pollutant levels in food by up to 50%. The company is active globally with a particular focus on China and the US.
- Therapeutic areas
- Other
- Modalities
- Microbial therapyLive biotherapeutic product therapy
- Industry
- Agriculture & AgTech
02
Partnerships
Strategic alliances with Chinese soil remediation companies including China Energy Conservation and Environment Protection GroupParticipation in THRIVE AgTech accelerator program at Western Growers Center for Innovation & Technology
Beyond the preview
Go deeper on MicroGen Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MicroGen Biotech.